🇺🇸 FDA
Patent

US 8962580

Chemical modifications of monomers and oligonucleotides with cycloaddition

granted A61KA61K31/713A61K47/544

Quick answer

US patent 8962580 (Chemical modifications of monomers and oligonucleotides with cycloaddition) held by Alnylam Pharmaceuticals, Inc. expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/713, A61K47/544, A61K47/64, A61P